Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 301–400 of 838
Yamashina, T., Baghdadi, M., Yoneda, A., Kinoshita, I., Suzu, S., Dosaka-Akita, H., & Jinushi, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2169 · Cited by 71
Dharshini, L. C. P., Rasmi, R. R., Kathirvelan, C., Kumar, K. M., Saradhadevi, K. M., & Sakthivel, K. M. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04266-z · Cited by 86
The Thyroid Hormone Receptors as Modulators of Skin Proliferation and Inflammation
Contreras‐Jurado, C., García-Serrano, L., Gómez-Ferrería, M., Costa, C., Paramio, J. M., & Aranda, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218487 · Cited by 78
Tétreault, M., Wang, M., Yang, Y., Travis, J., Yu, Q., Klein–Szanto, A. J., & Katz, J. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.048 · Cited by 69
Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.
Suganuma, M., Kurusu, M., Okabe, S., Sueoka, N., Yoshida, M., Wakatsuki, Y., & Fujiki, H. (2001) · PubMed · Cited by 69
Unleashing TNF cytotoxicity to enhance cancer immunotherapy
Freeman, A. J., Kearney, C. J., Silke, J., & Oliaro, J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.003 · Cited by 71
Ghirelli, C., Reyal, F., Jeanmougin, M., Zollinger, R., Sirven, P., Michea, P., Caux, C., Bendriss‐Vermare, N., Donnadieu, M., Caly, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2386 · Cited by 67
Singh, K. B., Maurya, B. K., & Trigun, S. K. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2306-x · Cited by 71
Toad Glandular Secretions and Skin Extractions as Anti‐Inflammatory and Anticancer Agents
Qi, J., Tan, C. K., Hashimi, S. M., Zulfiker, A. H. M., Good, D. M., & Wei, M. Q. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/312684 · Cited by 74
Heterogeneous Myeloid Cells in Tumors
Dou, A., & Fang, J. (2021) · Cancers · doi:10.3390/cancers13153772 · Cited by 78
FAT10 mediates the effect of TNF-α in inducing chromosomal instability
Ren, J., Wang, Y., Gao, Y., Mehta, S. B., & Lee, C. G. L. (2011) · Journal of Cell Science · doi:10.1242/jcs.087403 · Cited by 66
Tumour necrosis factor α confers an invasive, transformed phenotype on mammary epithelial cells
Montesano, R., Soulié, P., Eble, J. A., & Carrozzino, F. (2005) · Journal of Cell Science · doi:10.1242/jcs.02467 · Cited by 66
Oshima, M., Oshima, H., Matsunaga, A., & Taketo, M. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1936 · Cited by 66
Rodríguez‐Berriguete, G., Sánchez‐Espiridión, B., Cansino, J. R., Olmedilla, G., Martínez-Onsurbe, P., Sánchez‐Chapado, M., Paniagua, R., Fraile, B., & Royuela, M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.003 · Cited by 68
Lian, Z., Niwa, K., Tagami, K., Hashimoto, M., Gao, J., Yokoyama, Y., Mori, H., & Tamaya, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01154.x · Cited by 75
Suganuma, M., Kuzuhara, T., Yamaguchi, K., & Fujiki, H. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.1.001 · Cited by 65
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth
Baxendale, A. J., Dawson, C., Stewart, S. E., Mudaliar, V., Reynolds, G. M., Gordon, J., Murray, P. G., Young, L. S., & Eliopoulos, A. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208929 · Cited by 64
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Sheppard, S., Guedes, J., Mróz, A., Zavitsanou, A., Kudo, H., ROTHERY, S. M., Angelopoulos, P., Goldin, R. D., & Guerra, N. (2017) · Nature Communications · doi:10.1038/ncomms13930 · Cited by 69
Suzukawa, K., Weber, T. J., & Colburn, N. H. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110865 · Cited by 64
Menegazzi, M., Masiello, P., & Novelli, M. (2020) · Antioxidants · doi:10.3390/antiox10010018 · Cited by 78
Li, Q., Wang, L., Tan, W., Peng, Z. J., Luo, Y., Zhang, Y., Zhang, G., Na, D., Jin, P., Shi, T., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.005 · Cited by 72
Yen, C.-J., Izzo, J. G., Lee, D., Guha, S., Wei, Y., Wu, T., Chen, C., Kuo, H.-P., Hsu, J.-M., Sun, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5460 · Cited by 63
Association Between Pulmonary Mycobacterium Avium Complex Infection and Lung Cancer
Lande, L., Peterson, D. D., Gogoi, R. P., Daum, G. S., Stampler, K. M., Kwait, R. M., Yankowski, C., Hauler, K., Danley, J., Sawicki, K., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825abd49 · Cited by 67
Mad dogs, Englishmen and apoptosis: The role of cell death in UV-induced skin cancer
Guzmán, E. A., Langowski, J. L., & Owen‐Schaub, L. B. (2003) · APOPTOSIS · doi:10.1023/a:1024112231953 · Cited by 74
Kwong, J., Chan, F. L., Wong, K.-K., Birrer, M. J., Archibald, K. M., Balkwill, F. R., Berkowitz, R. S., & Mok, S. C. (2009) · Neoplasia · doi:10.1593/neo.09112 · Cited by 62
Self-citationZhao, C., Lü, X., Bu, X., Zhang, N., & Wang, W. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-419 · Cited by 69
Suganuma, M., Kurusu, M., Suzuki, K., Nishizono, A., Murakami, K., Fujioka, T., & Fujiki, H. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0652-x · Cited by 61
Carcinogenesis induced by foreign bodies
Moizhess, T. G. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908070043 · Cited by 67
Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Aggarwal, B. B., Sethi, G., Nair, S. A., & Ichikawa, H. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269235 · Cited by 70
The Skin: A Home to Multiple Classes of Epithelial Progenitor Cells
Yan, X., & Owens, D. M. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9022-4 · Cited by 64
Self-citationERK5 Is a Critical Mediator of Inflammation-Driven Cancer
Finegan, K. G., Madrigal, D. P., Hitchin, J. R., Davies, C. C., Jordan, A. M., & Tournier, C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-13-3043 · Cited by 64
Activated macrophages in the tumour microenvironment—dancing to the tune of TLR and NF‐κB
Hallam, S. L., Escorcio‐Correia, M., Soper, R., Schultheiss, A., & Hagemann, T. (2009) · The Journal of Pathology · doi:10.1002/path.2602 · Cited by 72
Luo, X., Hu, L., Zheng, H., Liu, M., Liu, X., Li, C., Qiu, Q., Zhao, Z., Cheng, X., Lai, C., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474973 · Cited by 64
Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia
Martín‐Oliva, D., O’Valle, F., Muñoz‐Gámez, J. A., Valenzuela, M. T., Núñez, M. I., Aguilar, M., de Almodóvar, J. M. R., del Moral, R. G., & Oliver, F. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207696 · Cited by 62
Hwang, M. K., Kang, N. J., Heo, Y., Lee, K. W., & Lee, H. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.021 · Cited by 64
Epidermal p65/NF‐κB signalling is essential for skin carcinogenesis
KIM, C. S., & Pasparakis, M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303541 · Cited by 60
Self-citationArdestani, S., Li, B., Deskins, D. L., Wu, H., Massion, P. P., & Young, P. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0002 · Cited by 68
Nakasone, Y., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Yanaba, M., Sato, S., Takehara, K., & Hasegawa, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.005 · Cited by 63
Ma, J., Li, Y., Duan, H., Rajeshkumar, S., & Li, X. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.10.158 · Cited by 61
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis
Fleischmann, R., Iqbal, I., & Stern, R. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.391 · Cited by 63
Immunomodulatory Potency of Microcystin, an Important Water-Polluting Cyanobacterial Toxin
Adamovský, O., Moosová, Z., Pekarová, M., Basu, A., Babica, P., Sindlerova, L. S., Kubala, L., & Bláha, L. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02049 · Cited by 58
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
Medler, J., Kucka, K., & Wajant, H. (2022) · Cancers · doi:10.3390/cancers14112603 · Cited by 66
dUev1a modulates TNF-JNK mediated tumor progression and cell death in Drosophila
Ma, X., Yang, L., Yang, Y., Li, M., Li, W., & Xue, L. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.05.013 · Cited by 64
Watanabe, T., Tsuge, H., Imagawa, T., Kise, D., Hirano, K., Beppu, M., Takahashi, A., Yamaguchi, K., Fujiki, H., & Suganuma, M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0733-y · Cited by 57
Wu, S.-T., Sun, G.-H., Hsu, C.-Y., Huang, C.-S., Wu, Y., Wang, H.-H., & Sun, K. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011058 · Cited by 61
Kim, J., Son, J. E., Jung, S. K., Kang, N. J., Lee, C. Y., Lee, K. W., & Lee, H. J. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001704 · Cited by 64
Devi, D. G., Cibin, T. R., Ramaiah, D., & Abraham, A. (2008) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2008.06.002 · Cited by 58
Targeting tumour-associated macrophages
Sica, A., Rubino, L., Mancino, A., Larghi, P., Porta, C., Rimoldi, M., Solinas, G., Locati, M., Allavena, P., & Mantovani, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1219 · Cited by 65
Tsuji, S., Kawai, N., Tsujii, M., Kawano, S., & Hori, M. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s1.22.x · Cited by 57
Wang, N., Thuraisingam, T., Fallavollita, L., Ding, A. H., Radzioch, D., & Brodt, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2638 · Cited by 62
Death Receptors and Their Ligands in Inflammatory Disease and Cancer
Annibaldi, A., & Walczak, H. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036384 · Cited by 64
Martinez, R. M., Pinho-Ribeiro, F. A., Steffen, V. S., Caviglione, C. V., Vignoli, J. A., Baracat, M. M., Georgetti, S. R., Verri, W. A., Jr., & Casagrande, R. (2015) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2015.03.030 · Cited by 71
Proprotein convertases: Key players in inflammation-related malignancies and metastasis
Siegfried, G., Descarpentrie, J., Évrard, S., & Khatib, A. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.027 · Cited by 60
Membrane Trafficking of Death Receptors: Implications on Signalling
Schneider‐Brachert, W., Heigl, U., & Ehrenschwender, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714475 · Cited by 63
Anuja, K., Roy, S., Ghosh, C., Gupta, P., Bhattacharjee, S., & Banerjee, B. (2016) · Inflammation Research · doi:10.1007/s00011-016-0985-3 · Cited by 64
Chen, Y., Li, R., Chang, Q., Dong, Z., Yang, H., & Xu, C. (2019) · Toxins · doi:10.3390/toxins11010017 · Cited by 54
Obesity as an important risk factor for certain types of cancer.
Davoodi, S. H., Malekshahabi, T., Moghadam, A. M., Shahbazi, R., & Esmaeili, S. (2013) · PubMed Central · Cited by 83
Shan, B., Zhuo, Y., Chin, D., Morris, C. A., Morris, G. F., & Lasky, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406293200 · Cited by 56
The Role of Death Receptor Ligands in Shaping Tumor Microenvironment
Whiteside, T. L. (2006) · Immunological Investigations · doi:10.1080/08820130600991893 · Cited by 61
Warren, M. A., Shoemaker, S. F., Shealy, D. J., Bshara, W., & Ip, M. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0358 · Cited by 53
Wheeler, D. L., Martin, K. E., Ness, K. J., Li, Y., Dreckschmidt, N. E., Wartman, M., Ananthaswamy, H. N., Mitchell, D. L., & Verma, A. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1881 · Cited by 53
Ren, Q., Kari, C., Quadros, M. R. D., Burd, R., McCue, P., Dicker, A. P., & Rodeck, U. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4158 · Cited by 53
Grigorakaki, C., Morceau, F., Chateauvieux, S., Dicato, M. A., & Diederich, M. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.030 · Cited by 67
Protein kinase Cε and development of squamous cell carcinoma, the nonmelanoma human skin cancer
Verma, A. K., Wheeler, D. L., Aziz, M. H., & Manoharan, H. T. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20230 · Cited by 51
Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
Yuan, Q., Sun, N., Zheng, J., Wang, Y., Yan, X., Mai, W., Liao, Y., & Chen, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01502 · Cited by 57
Ishida, Y., Kuninaka, Y., Yamamoto, Y., Nosaka, M., Kimura, A., Furukawa, F., Mukaida, N., & Kondo, T. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.02.023 · Cited by 51
Tellechea, M., Buxadé, M., Tejedor, S., Aramburu, J., & López-Rodríguez, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1601942 · Cited by 50
Marsh, H. P., Haldar, N., Bunce, M., Marshall, S. E., Monnier, K. L., Winsey, S., Christodoulos, K., Cranston, D., Welsh, K. I., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601165 · Cited by 50
Perspectives on cancer immuno‐epidemiology
Nakachi, K., Hayashi, T., Imai, K., & Kusunoki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03178.x · Cited by 58
Anti-TNF Antibodies: Lessons from the Past, Roadmap for the Future
Shealy, D. J., & Visvanathan, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_5 · Cited by 56
Thyroid hormone signaling controls hair follicle stem cell function
Contreras‐Jurado, C., Lorz, C., García-Serrano, L., Paramio, J. M., & Aranda, A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-07-1251 · Cited by 51
Proteinase-Activated Receptor-2 (PAR2): A Tumor Suppressor in Skin Carcinogenesis
Rattenholl, A., Seeliger, S., Buddenkotte, J., Schön, M., Schön, M. P., Ständer, S., Vergnolle, N., & Steinhoff, M. S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700847 · Cited by 49
Bruera, S., & Suarez-Almazor, M. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.928390 · Cited by 57
P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells
Ricote, M., García‐Tuñón, I., Fraile, B., Fernández, C., Aller, P., Paniagua, R., & Royuela, M. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0086-9 · Cited by 48
Ding, J., Zhang, X., Li, J., Song, L., Ouyang, W., Zhang, D., Xue, C., Costa, M., Melendez, J. A., & Huang, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604798200 · Cited by 49
The risk of melanoma and hematologic cancers in patients with psoriasis
Reddy, S. P., Martires, K. J., & Wu, J. J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.047 · Cited by 47
Cui, L., Guo, X., Wei, J., Liu, F. F., Fan, Y., Lang, R., Gu, F., Zhang, X. M., & Fu, L. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03128.x · Cited by 47
Yan, Y., Li, J., Ouyang, W., Ma, Q., Hu, Y., Zhang, D., Ding, J., Qu, Q., Subbaramaiah, K., & Huang, C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03014 · Cited by 51
Effect of Tumour Necrosis Factor-Alpha on Estrogen Metabolic Pathways in Breast Cancer Cells
Kamel, M., Shouman, S. A., El-Merzebani, M. M., Kilic, G. S., Veenstra, T. D., SAEED, M. K., Wagih, M., Diaz‐Arrastia, C., Patel, D., & Salama, S. (2012) · Journal of Cancer · doi:10.7150/jca.4584 · Cited by 49
Inflammation, Tumor Necrosis Factor and Wnt Promotion in Gastric Cancer Development
Oguma, K., Oshima, H., & Oshima, M. (2010) · Future Oncology · doi:10.2217/fon.10.13 · Cited by 48
Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner
Xu, X., Meng, Q., Erben, U., Wang, P., Glauben, R., Kühl, A. A., Wu, H., Ma, C. W., Hu, M., Wang, Y., et al. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.103 · Cited by 45
Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
Mohan Shankar, G., Alex, V. V., Amrutha Nisthul, A., Bava, S. V., Sundaram, S., Retnakumari, A. P., Sadasivan, C., & Anto, R. J. (2019) · Cell Proliferation · doi:10.1111/cpr.12710 · Cited by 46
An unexpected role for keratin 10 end domains in susceptibility to skin cancer
Chen, J., Cheng, X., Merched-Sauvage, M., Caulín, C., Roop, D. R., & Koch, P. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03298 · Cited by 51
Activation of the α-Secretase Processing of AβPP as a Therapeutic Approach in Alzheimer's Disease
Vincent, B., & Govitrapong, P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110218 · Cited by 56
Inflammation and Prostate Cancer: A Future Target for Prevention and Therapy?
Stock, D., Groome, P. A., & Siemens, D. R. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.09.006 · Cited by 52
Hu, L., Edamatsu, H., Takenaka, N., Ikuta, S., & Kataoka, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901816 · Cited by 49
Macrophage–tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands
Schmidt, T., Batalla, I. B., Schultze, A., & Loges, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0863-7 · Cited by 52
Lalli, A., Tilakaratne, W. M., Ariyawardana, A., Fitchett, C., Leigh, I. M., Hagi‐Pavli, E., Cruchley, A. T., Parkinson, E. K., Teh, M., Fortune, F., et al. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00609.x · Cited by 45
Eryngium foetidum Suppresses Inflammatory Mediators Produced by Macrophages
Mekhora, C., Muangnoi, C., Chingsuwanrote, P., Dawilai, S., Svasti, S., Chasri, K., & Tuntipopipat, S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.653 · Cited by 51
Chemokine sequestration by atypical chemokine receptors
Hansell, C. A. H., Simpson, C. V., & Nibbs, R. J. B. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341009 · Cited by 50
Nitric oxide does not mediate but inhibits transformation and tumor phenotype.
Dhar, A., Brindley, J. M., Stark, C., Citro, M. L., Keefer, L. K., & Colburn, N. H. (2003) · PubMed · Cited by 50
Dermal mast cells affect the development of sunlight‐induced skin tumours
Sarchio, S. N. E., Kok, L., O’Sullivan, C., Halliday, G. M., & Byrne, S. N. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01438.x · Cited by 44
TNF-α Regulates the Effects of Irradiation in the Mouse Bone Marrow Microenvironment
Cachaço, A. S., Carvalho, T., SANTOS, A. C. D. S., Igreja, C., Fragoso, R., Osório, C., Ferreira, M. M., Serpa, J., Correia, S., Pinto‐do‐Ó, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008980 · Cited by 47
Autoimmunity as a Double Agent in Tumor Killing and Cancer Promotion
Toomer, K. H., & Chen, Z. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00116 · Cited by 47
Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike
Figura, N., Marano, L., Moretti, E., & Ponzetto, A. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i1.40 · Cited by 54
Lawrence, T., Hagemann, T., & Balkwill, F. (2007) · Science · doi:10.1126/science.1146052 · Cited by 44
Self-citationRong, J., Xu, L., Hu, Y., Liu, F., Yu, Y., Guo, H., Ni, X., Huang, Y., Zhao, L., & Wang, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01563-7 · Cited by 48
TNF: A Tumor-Suppressing Factor or a Tumor-Promoting Factor?
Balkwill, F. R., & Joffroy, C. M. (2010) · Future Oncology · doi:10.2217/fon.10.155 · Cited by 47
Self-citationKyula, J., Khan, A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S. H. H., Pencavel, T. D., Touchefeu, Y., Seth, R., et al. (2013) · Oncogene · doi:10.1038/onc.2013.112 · Cited by 48
Chaudhry, S. I., Hooper, S., Nye, E., Williamson, P., Harrington, K., & Sahai, E. (2013) · Oncogene · doi:10.1038/onc.2012.91 · Cited by 43
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.